Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1300 of 1631 entries
View as:

Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

Phase: N/A Priority: Normal
NCT ID: NCT00185458 Org: User:
Start: 05/31/00 End: 05/31/08 Due: 05/31/09

Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population

Phase: N/A Priority: Normal
NCT ID: NCT01450592 Org: User:
Start: 05/31/12 End: 09/30/12 Due: 09/30/13

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Phase: N/A Priority: Normal
NCT ID: NCT00652418 Org: User:
Start: 07/31/04 End: 10/31/04 Due: 10/31/05

Bioequivalence Study of Rivaroxaban

Phase: N/A Priority: Normal
NCT ID: NCT02537457 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

Self Selection Trial of Naproxen Sodium

Phase: N/A Priority: Normal
NCT ID: NCT01383486 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

YAZ, Oral Contraceptive Registration in China

Phase: N/A Priority: Normal
NCT ID: NCT00819312 Org: User:
Start: 12/31/08 End: 01/31/11 Due: 01/31/12

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Phase: N/A Priority: Normal
NCT ID: NCT01191385 Org: User:
Start: 11/30/10 End: 12/31/13 Due: 12/31/14

Sun Protection Factor Assay (SPF Assay 200/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02930759 Org: User:
Start: 10/12/16 End: 10/13/16 Due: 10/13/17

Fast & Fed Pharmacokinetic (PK) Study

Phase: N/A Priority: Normal
NCT ID: NCT00692016 Org: User:
Start: 01/31/08 End: 03/31/08 Due: 03/31/09

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04903821 Org: User:
Start: 06/01/21 End: 03/15/22 Due: 03/15/23

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT02940002 Org: User:
Start: 10/12/16 End: 03/17/17 Due: 03/17/18

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00099502 Org: User:
Start: 11/30/03 End: 08/31/07 Due: 08/31/08

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01248481 Org: User:
Start: 09/30/10 End: 07/31/12 Due: 07/31/13

GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01095081 Org: User:
Start: 07/31/10 End: 04/30/13 Due: 04/30/14

Study on Medical Records of Women Using an Intrauterine Device (IUD) to Analyze the Risks That the IUD Will be Expelled or Perforates the Womb in Relation to Breastfeeding, the Point in Time When the IUD Was Inserted After Childbirth and in Relation to Different Types of IUDs

Phase: N/A Priority: Normal
NCT ID: NCT03754556 Org: User:
Start: 12/03/18 End: 11/29/19 Due: 11/29/20

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT00969319 Org: User:
Start: 09/30/09 End: 02/28/14 Due: 02/28/15

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT05511038 Org: User:
Start: 08/26/22 End: 04/16/24 Due: 04/16/25

Sun Protection Factor Assay (SPF Assay 19008)

Phase: N/A Priority: Normal
NCT ID: NCT02815202 Org: User:
Start: 06/28/16 End: 06/30/16 Due: 06/30/17

Pearl Index Study With Low Dose Combined Oral Contraceptive

Phase: N/A Priority: Normal
NCT ID: NCT00220324 Org: User:
Start: 02/29/04 End: 11/30/05 Due: 11/30/06

Depression and Fatigue in MS Patients Treated With Betaferon.

Phase: N/A Priority: Normal
NCT ID: NCT01354665 Org: User:
Start: 05/31/10 End: 06/30/13 Due: 06/30/14

STEPS Trial - Spheramine Safety and Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT00206687 Org: User:
Start: 01/08/03 End: 05/14/12 Due: 05/14/13

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05481528 Org: User:
Start: 08/19/22 End: 04/28/23 Due: 04/28/24

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04704154 Org: User:
Start: 02/03/21 End: 03/29/24 Due: 03/29/25

ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00555919 Org: User:
Start: 03/31/08 End: 03/31/11 Due: 03/31/12

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Phase: N/A Priority: Normal
NCT ID: NCT05461807 Org: User:
Start: 07/14/22 End: 10/05/22 Due: 10/05/23